THERE'S BEEN A wave of new therapies for Alzheimer’s disease released over the last few years. But nothing would be as revolutionary as simply taking a pill to slow down cognitive decline. Better yet, ...
The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...
The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...
Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...
A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...
New research reveals that NAD+ supplements may slow aging and boost cellular health, but experts urge caution and more ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
The drug, Lecanemab, could be available to some Ottawa patients within months. But it is not yet covered by provincial drug ...
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
Antidepressants can be very effective, but they also come with side effects that vary from one drug to the next, supporting ...
Shilajit may contain heavy metals, including arsenic, lead, and mercury, that can be toxic to the body. Shilajit may interact with hormonal medications, chemotherapy, and aspirin. Shilajit should not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback